BDBM573853 2-amino-9- [(2aR,5S,6aS,7R,8R,9aR,12S,14R,14aS,15R)-8- (6-amino-9H-purin-9-yl)-5,7,12-trihydroxy-5,12- dioxidohexahydro-6aH-2a,14- (epoxymethano)furo[3,2-d]oxeto[2,3- k][1,3,7,9,2,8]tetraoxadiphosphacyclotridecin- 15(2H,3H)-yl]-1,9-dihydro-6H-purin-6-one::US11453697, Example 17

SMILES Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@@]23COC2[C@@H]1OP(O)(=O)OC[C@H]1O[C@H]([C@@H](O)C1OP(O)(=O)OC3)n1cnc2c(N)ncnc12

InChI Key InChIKey=MCJXJJRKNPECIB-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 573853   

LigandPNGBDBM573853(US11453697, Example 17 | 2-amino-9- [(2aR,5S,6aS,7...)
Affinity DataEC50:  121nMAssay Description:The compounds were serially titrated by the Hamilton STARPlus CORE in a 96-well plate (Greiner, #651201) using a 1:3 ten-point dose response format. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
Go to US Patent